The Leukemia & Lymphoma Society's (LLS's) Oversight Committees are comprised of leading experts in their fields. Committee members are volunteers who give their time and talent to LLS and receive no compensation for their generous support.
Therapy Acceleration Program Committee
Provides oversight and guidance on LLS’s Therapy Acceleration Program (TAP), a strategic venture philanthropy initiative through which LLS partners directly with biotechnology companies and medical institutions to help accelerate the development of promising therapies
Casey Cunningham, MD (Chair) +
Santé Ventures
Giulio Draetta, MD, PhD
The University of Texas MD Anderson Cancer Center
Christoper Flowers, MD, MS, FASCO +
The University of Texas MD Anderson Cancer Center
Patrick Fortune, PhD, MBA
Partners Heathcare Systems
Laura Kaufman, PhD, DABT
Private Consultant
Ronald Levy, MD
Stanford University School of Medicine
Vern Norviel, Esq.
Wilson Sonsini Goodrich & Rosati
Robert Rosen, JD +
Grewhawke Capital Advisors
Steven Rosen, MD, FACP
City of Hope
Robert Spiegel, MD, FACP
Spiegel Consulting LLC
David Weinstock, MD
Dana-Farber Cancer Institute
+ National Board Member